Company Valuation: Takeda Pharmaceutical Company Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2022 2023 2024 2025 2026 2027 2028 2029
Market Cap 1 5,423,454 6,762,204 6,564,378 6,749,675 8,948,061 11,063,931 - -
Change - 24.68% -2.93% 2.82% 32.57% 23.65% - -
Enterprise Value (EV) 1 8,919,170 10,611,015 10,950,330 10,725,175 5,130,461 15,013,439 14,778,378 14,436,127
Change - 18.97% 3.2% -2.06% -52.16% 192.63% -1.57% -2.32%
P/E 23.8x 21.3x 45.4x 64.6x 46.4x 49.2x 33.9x 27.6x
PBR 0.95x 1.06x 0.9x 1x 1.2x 1.49x 1.49x 1.48x
PEG - 0.5x -0.8x -2.5x 0.6x 3.2x 0.8x 1.2x
Capitalization / Revenue 1.52x 1.68x 1.54x 1.47x 1.99x 2.35x 2.29x 2.23x
EV / Revenue 2.5x 2.63x 2.57x 2.34x 1.14x 3.18x 3.06x 2.91x
EV / EBITDA 8.54x 9.19x 11.6x 9.71x 4.54x 12.3x 11.1x 10.3x
EV / EBIT 19.4x 21.6x 51.1x 31.3x 12.6x 32.3x 23.4x 19.7x
EV / FCF 8.92x 28.7x 43.4x 15.5x 8.14x 26.8x 20.2x 18.6x
FCF Yield 11.2% 3.49% 2.31% 6.43% 12.3% 3.73% 4.96% 5.39%
Dividend per Share 2 180 180 188 196 200 204.3 208.4 215.8
Rate of return 5.15% 4.14% 4.49% 4.44% 3.53% 2.95% 3.01% 3.12%
EPS 2 147.1 204.3 92.09 68.36 122 140.8 204.4 251.1
Distribution rate 122% 88.1% 204% 287% 164% 145% 102% 85.9%
Net sales 1 3,569,006 4,027,478 4,263,762 4,581,600 4,505,700 4,715,114 4,827,468 4,966,959
EBITDA 1 1,043,995 1,154,905 942,077 1,103,982 1,129,888 1,223,584 1,329,806 1,397,131
EBIT 1 460,844 490,505 214,100 342,600 408,800 465,274 630,954 731,934
Net income 1 230,059 317,017 144,067 107,900 191,800 215,543 342,828 411,150
Net Debt 1 3,495,716 3,848,811 4,385,952 3,975,500 -3,817,600 3,949,508 3,714,447 3,372,196
Reference price 2 3,498.00 4,350.00 4,184.00 4,413.00 5,664.00 6,926.00 6,926.00 6,926.00
Nbr of stocks (in thousands) 1,550,444 1,554,530 1,568,924 1,529,498 1,579,813 1,597,449 - -
Announcement Date 5/11/22 5/11/23 5/9/24 5/8/25 5/13/26 - - -
1JPY in Million2JPY
Estimates

P/E, Detailed evolution



P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
49.18x3.18x12.27x2.95% 69.2B
42.25x14.3x30.31x0.47% 1,286B
41.82x7.01x19.73x1.87% 688B
37.62x8.63x17.81x2.34% 521B
21.75x5.27x13.2x2.48% 386B
104.88x5.98x25.49x2.3% 364B
24x5.82x14.17x2.73% 302B
24.25x4.85x13.63x1.8% 287B
24.04x7.38x13.56x2.17% 252B
-39.49x7.32x46.07x1.96% 208B
Average 33.03x 6.97x 20.62x 2.11% 436B
Weighted average by Cap. 37.75x 8.86x 22.52x 1.7%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Takeda Pharmaceutical Company Limited

Historical PBR trend

Valuation ratios - PBR - Takeda Pharmaceutical Company Limited

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Takeda Pharmaceutical Company Limited

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Takeda Pharmaceutical Company Limited


Year-on-year evolution of the Yield

Valuation ratios - Yield - Takeda Pharmaceutical Company Limited
  1. Stock Market
  2. Stocks
  3. 4502 Stock
  4. Valuation Takeda Pharmaceutical Company Limited